Sign in

James Meer

Senior Vice President, Chief Accounting Officer at Elanco Animal Health
Executive

About James Meer

James Meer, 55, is Senior Vice President and Chief Accounting Officer at Elanco (ELAN). He joined Elanco in September 2018 after CFO and senior finance roles in healthcare tech and enterprise software, and earlier accounting/strategy roles at 3M (Aearo), Hillrom, Hillenbrand, and EY; he holds a bachelor’s in accounting/business (Marian University) and an MBA (Xavier University) . Company performance context: 2024 revenue was $4.439B with 3% organic constant-currency growth and adjusted EBITDA of $910M, reflecting portfolio momentum and deleveraging initiatives .

Past Roles

OrganizationRoleYearsStrategic Impact
Elanco Animal HealthSVP, Chief Accounting Officer2018–presentPrincipal accounting leadership at newly independent animal health company
Healthx, Inc.Chief Financial Officer2017–2018Led finance at healthcare technology firm during scale-up phase
AppirioSenior Vice President, Finance2014–2017Drove finance for IT consulting amid growth and client delivery expansion
Salesforce (ExactTarget)Vice President & Corporate Controller2011–2014Led corporate controllership post-acquisition, strengthened reporting controls
3M (Aearo Technologies)Various finance/accounting/strategy rolesPrior to 2011Progressively responsible finance roles in industrial safety products
HillromVarious finance rolesPrior to 2011Finance leadership in medical technology operations
Hillenbrand IndustriesVarious finance rolesPrior to 2011Financial planning and corporate development exposure
Ernst & Young LLPAssurance/AdvisoryPrior to 2011Public accounting foundation in auditing and controls

External Roles

OrganizationRoleYearsNotes
No external directorships or public boards disclosed for Meer

Fixed Compensation

ComponentTermsDate/PeriodNotes
Base salary$270,000September 2018 hireAs Chief Accounting Officer per 8-K
Target annual bonus26% of base salarySeptember 2018Under Elanco cash performance bonus plan
Sign-on bonus$100,000 cashSeptember 2018Sign-on, paid at hire
Equity grant (RSUs)$140,000 grant-date fair valueSeptember 2018RSUs vest in equal installments over 2 years

Performance Compensation

MetricWeightingTargetActualPayoutVesting
Not disclosed for Meer

Company incentive metrics (context – NEO program):

Metric2024 Threshold2024 Target2024 ActualCorporate Bonus Multiple
Elanco Cash Earnings (ECE) (economic profit)$(860)M$(520)M$(509)M103%
Performance Awards (Adjusted EBITDAR)Two-year cyclePrior-year Adjusted EBITDAR plus required return2023-2024 cycle paid at 90.36% avg multiple for NEOsPays after performance period

Notes: Elanco’s annual cash incentive is based on year-over-year change in ECE; long-term PAs are based on Adjusted EBITDAR over a two-year period. The company removed the impact of the 2024 aqua divestiture from both ECE and PA calculations to avoid undue penalty from portfolio optimization .

Equity Ownership & Alignment

Policy/PracticeDetailsApplicabilitySource
Executive stock ownership guidelinesCEO: ≥6x salary; other executive officers: ≥3x salary; hold ≥50% of vested equity until compliantExecutive officers (includes CAO role)
Anti-hedging/anti-pledgingExecutives and directors prohibited from hedging or pledging Elanco stockAll executives/directors
ClawbacksRequired NYSE-compliant recoupment for restatements; supplemental policy for misconduct/restatements, recovery up to 3 yearsExecutives and senior management
Deferred compensationAbility to defer base/bonus and full-value equity; 1:1 match on deferrals into Elanco stock up to 6% of base+bonus (2-year cliff vest)Senior management incl. executives
Beneficial ownership disclosureProxy tables list directors/NEOs; individual CAO holdings not separately disclosedMeer’s specific share count not disclosed in proxy

Employment Terms

TermDetailsNotesSource
Employment startSeptember 2018Became principal accounting officer at IPO separation
Initial appointment compensationBase $270k; target bonus 26%; $100k sign-on; $140k RSUs (2-year vest)Per Item 5.02 8-K at hire
Employment agreementsCompany states NEOs have no individual employment agreements; plan-based benefits applyCompany-level policy reference
Executive Severance Plan (non-CIC)Lump sum = 1x base + 1x target bonus for executives (CEO 2x), plus 12 months benefit contributions (CEO 24 months), and outplacementApplies to eligible senior executives; adopted Nov 2020
Change-in-Control Plan (CIC)Double-trigger; severance = 2 years’ base + 2x target bonus; 18 months benefit continuation; no excise tax gross-upsNEO plan; company adopted CIC plans broadly at IPO
Equity treatment on termination/CICCIC: RSUs/options fully vest; PAs vest at target. Non-CIC qualifying termination: pro-rata vesting per award termsAward acceleration mechanics

Investment Implications

  • Disclosure depth: Meer is a key finance leader but not a Named Executive Officer; detailed annual pay outcomes and current beneficial ownership aren’t disclosed in proxy tables, limiting direct pay-for-performance calibration at the individual level. Monitor Section 16 Form 4 filings for any selling pressure or alignment signals going forward.
  • Alignment frameworks: Strong governance mitigants—3x salary ownership guideline for executive officers, anti-hedging/anti-pledging, and robust clawbacks—support shareholder alignment and reduce red-flag risks around hedging/pledging and windfall retention .
  • Incentive design signal: Company-wide incentives emphasize cash earnings (ECE) and Adjusted EBITDAR, with transparent adjustments for portfolio actions (aqua divestiture). 2024 ECE delivered a 103% corporate multiple, suggesting modest over-target performance and disciplined capital accountability—constructive for finance leadership credibility .
  • Team continuity: CFO transition in July 2025 may raise near-term finance organization execution risk; continued presence of a seasoned CAO (Meer) helps continuity in disclosure controls and reporting quality during leadership change .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%